Sales: $2.9 billion
Key Personnel: Sir Christopher Gent, chairman; Sir Andrew Witty, chief executive officer; Emma Walmsley, president, consumer healthcare worldwide.
Major Products: Oral care—Aquafresh, Biotene, Dr Best, Macleans, Odol and Sensodyne; Denture care—Polident, Poligrip and Corega.
New Products: Sensodyne Repair Sensitive Teeth toothpaste.
Comments: With oral care sales of nearly $3 billion, GlaxoSmithKline is a major player in the global personal care market—even if toothpaste and related products account for just a fraction of the pharmaceutical giant’s corporate sales of $42.6 billion.
Oral care sales rose 5% last year, driven by sales of Sensodyne Sensitivity & Acid Erosion, which posted a 15% increase in sales. GSK said that strong results from denture care products also helped to offset a 2% decline in Aquafresh sales.
GSK says its new Sensodyne Repair Sensitive Teeth’s active ingredient, stannous fluoride, forms a repairing layer over sensitive teeth when used twice a day.
For the first quarter of 2013, oral care sales were $749 million, an increase of less than 2%.